Subscribe

Recent Articles

Popular Posts

Site search

Follow Us

Archive for November, 2005

Licensing Executives Society

Written by on Monday, November 28th, 2005

Licensing Executives Society

643 total views, no views today

Share On Facebook
Share On Twitter
Share On Google Plus
Share On Linkedin

Category: Links of Interest  |  Comments Off on Licensing Executives Society

BIO

Written by on Monday, November 28th, 2005

BIO: Biotechnology Industry Organization

621 total views, no views today

Share On Facebook
Share On Twitter
Share On Google Plus
Share On Linkedin

Category: Links of Interest  |  Comments Off on BIO

Baybio

Written by on Monday, November 28th, 2005

Baybio: Northern California’s Life Sciences Association

603 total views, no views today

Share On Facebook
Share On Twitter
Share On Google Plus
Share On Linkedin

Category: Links of Interest  |  Comments Off on Baybio

BIOCOM

Written by on Monday, November 28th, 2005

BIOCOM: Life Science Industry Association in San Diego and Southern California

650 total views, no views today

Share On Facebook
Share On Twitter
Share On Google Plus
Share On Linkedin

Category: Links of Interest  |  Comments Off on BIOCOM

Stem Cell Initiative: Where We are One Year Later

Written by on Sunday, November 27th, 2005

In today’s San Jose Mercury News, Steve Johnson writes about where California and other states are one year after California voters approved the $3 billion stem cell initiative. According to Johnson, “[S]o far, stem-cell scientists, companies, and their supporters have little to cheer about.”

Johnson further reports:

California’s program, which was designed to get around severe federal limits on such research, has been bottled up by two lawsuits. And because of a national stem-cell backlash, only two states — Connecticut and Illinois — allocated money for stem-cell studies this year, according to the National Conference of State Legislators.

Worse for stem-cell advocates, several states — including South Dakota, Arizona and Nebraska — passed laws this year limiting stem-cell research. In other states, the issue sparked nasty battles likely to rage into next year’s legislative session.

Stem cell research, of course, is controversial because human embryos are destroyed in the process. Also at issue is a laboratory technique caled somatic cell nuclear transfer, where the nucleus of a cell is place into an egg which has already had its nucleus removed.

Advocates for stem cell research argue that this kind of research is critical because of its potential for curing such medical conditions such as Parkinson’s disease and and spinal cord injuries.

Due to the continuing controversy, however, the advancement of stem cell research continues to be thwarted. As Johnson writes:

So far, only five states have passed money for stem-cell studies, and merely a trickle of that has gotten to researchers.

The first to approve financing was Ohio. In 2003 it set aside $19.5 million, some of which already has been given to scientists. New Jersey approved $9.5 million in May 2004 and another $10.5 million this year, with $5 million due to be awarded to researchers in December.

This year, Connecticut followed suit with $100 million and Illinois set aside $10 million, although neither is expected to begin spending the money until 2006.

The biggest state program by far is California’s $3 billion stem-cell research effort, which voters approved in a November 2004 ballot initiative. But lawsuits by anti-abortion activists, who claim California’s program lacks proper state oversight and is riddled with conflicts of interest, have delayed the sale of state bonds needed to finance the effort.

When you look at this issue, you have to wonder if state-funded research is really a workable solution. If California, one of the most liberal and progressive states in the country, has difficulty getting a stem cell research program off the ground, it seems unlikely that other states could make it happen either.

Whether you oppose or support the concept of stem cell research, the fact remains that the allocation of $3 billion from a state budget is a tremendous allocation of resources, and it is inevitable that the allocation of that money will become entwined with political concerns.

So where will we be a year later on this issue? It’s not out of the question that we will be at the very same place where we are now.

765 total views, 1 views today

Share On Facebook
Share On Twitter
Share On Google Plus
Share On Linkedin

Category: Biotech Legislative Developments  |  Comments Off on Stem Cell Initiative: Where We are One Year Later

The Role of Marketing in the BioScience Industry

Written by on Saturday, November 26th, 2005

The event The Role of Marketing in the BioScience Industry will be held at Squire Sanders in Palo Alto, CA at 6:30 p.m. on February, 24th, 2006. The event will explore the integral role of certain marketing/business functions from marketing research to business development in building a successful bioscience company. For more information, contact ysyang@stanford.edu or slcheng1@yahoo.com.

778 total views, no views today

Share On Facebook
Share On Twitter
Share On Google Plus
Share On Linkedin

Category: Biotech Industry Events  |  Comments Off on The Role of Marketing in the BioScience Industry

The Secrets of My Success for Building Value

Written by on Saturday, November 26th, 2005

The event The Secrets of My Success for Building Value will be held on the 23rd of February, 2006 from 7 a.m.-9 a.m. at the Grand Pacific Palisades, 5805 Armada Drive, Carlsbad, California 92008. Leaders at San Diego bioscience companies will discuss how they build value for their companies and investors.

598 total views, no views today

Share On Facebook
Share On Twitter
Share On Google Plus
Share On Linkedin

Category: Biotech Industry Events  |  Comments Off on The Secrets of My Success for Building Value

Corporate IP Management Obligations and Responsibilities in the Post Sox World

Written by on Saturday, November 26th, 2005

The Licensing Executives Society’s Silicon Valley Chapter will be hosting the event Corporate IP Management Obligations and Responsibilities in the Post SOX World on Wednesday, February 22, 2006. The speaker for this event will be Gary Bender of Ernst & Young.

647 total views, no views today

Share On Facebook
Share On Twitter
Share On Google Plus
Share On Linkedin

Category: Biotech Industry Events  |  Comments Off on Corporate IP Management Obligations and Responsibilities in the Post Sox World

LES 2006 Winter Meeting

Written by on Saturday, November 26th, 2005

The LES 2006 Winter Meeting will be held in Pasadena, CA from February 22-24 at the Pasadena Ritz Carlton Huntington Hotel.

587 total views, 1 views today

Share On Facebook
Share On Twitter
Share On Google Plus
Share On Linkedin

Category: Biotech Industry Events  |  Comments Off on LES 2006 Winter Meeting

US/Japan Biobridge

Written by on Saturday, November 26th, 2005

The US/Japan Biobridge event will be held on February 22nd, 2006 at 7:30 a.m. at the Weaver Center, University of California San Diego. The event will address business trends and opportunities between Japan and the United States.

541 total views, no views today

Share On Facebook
Share On Twitter
Share On Google Plus
Share On Linkedin

Category: Biotech Industry Events  |  Comments Off on US/Japan Biobridge

© 2008-2015 The Prinz Law Office. All rights reserved.

The Prinz Law Office | Silicon Valley, CA | Los Angeles, CA | Orange County, CA | San Diego, CA | Atlanta, GA | Tel: 1.800.884.2124

Mailing Address: 117 Bernal Rd., Suite 70-110, San Jose, CA 95119; Silicon Valley Office: San Jose- 2033 Gateway Place, 5th Floor, San Jose, CA 95110 (408)884-2854; Los Angeles Office: 3110 Main St., Building C, Santa Monica, CA 90405 (310)907-9218; Orange County Office: 100 Spectrum Center Drive, 9th Floor, Irvine, CA 92618 (949)236-6777; San Diego Office: 4455 Murphy Canyon Road, Suite 100, San Diego, CA 92123 (619)354-2727 Atlanta Office: 1000 Parkwood Circle, Suite 900, Atlanta, Georgia 30339 (404)479-2470

Biotech Lawyer & Attorney: Serving Silicon Valley, San Jose, San Francisco, Santa Cruz, San Diego, Los Angeles, Orange County, Irvine, Anaheim, Santa Monica, Silicon Beach, Santa Barbara, Sacramento, Atlanta. Licensed in California and Georgia.
Follow

Get every new post delivered to your Inbox

Join other followers